Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis
dc.contributor.author | Szabo, Gyongyi | |
dc.contributor.author | Iracheta-Vellve, Arvin | |
dc.date | 2022-08-11T08:08:34.000 | |
dc.date.accessioned | 2022-08-23T15:59:24Z | |
dc.date.available | 2022-08-23T15:59:24Z | |
dc.date.issued | 2015-09-01 | |
dc.date.submitted | 2016-05-09 | |
dc.identifier.citation | Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S18-23. doi: 10.1016/j.clinre.2015.06.012. Epub 2015 Jul 26. <a href="http://dx.doi.org/10.1016/j.clinre.2015.06.012">Link to article on publisher's site</a> | |
dc.identifier.issn | 2210-7401 (Linking) | |
dc.identifier.doi | 10.1016/j.clinre.2015.06.012 | |
dc.identifier.pmid | 26216030 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/30660 | |
dc.description | <p>Co-author Arvin Iracheta-Vellve is a doctoral student in the Translational Science Program in the Graduate School of Biomedical Sciences (GSBS) at UMass Medical School.</p> | |
dc.description.abstract | Upregulation of the inflammatory cascade is a major element both in the progression of steatohepatitis to severe alcoholic hepatitis as well as in the progression of NASH to advanced NASH with fibrosis. The mechanisms underpinning these changes are only partially understood. Activation of the inflammatory cascade requires multiple stimuli and in this report, we discuss the role of inflammasomes that activate IL-1beta as well as the sterile and pathogen-derived danger signals that results in inflammasome activation and inflammation in alcoholic and non-alcoholic steatohepatitis. The dynamics of inflammasome activation, the cell types involved and the trigger signals appear to be somewhat different between ASH and NASH. Further studies are needed to dissect the pathology-related differences between these two major forms of steatohepatitis. Clinical and therapeutic implications of inflammasome activation in steatohepatitis are also discussed. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=26216030&dopt=Abstract">Link to Article in PubMed</a> | |
dc.relation.url | http://dx.doi.org/10.1016/j.clinre.2015.06.012 | |
dc.subject | Digestive System Diseases | |
dc.subject | Gastroenterology | |
dc.subject | Hepatology | |
dc.subject | Immunity | |
dc.subject | Immunopathology | |
dc.title | Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis | |
dc.type | Journal Article | |
dc.source.journaltitle | Clinics and research in hepatology and gastroenterology | |
dc.source.volume | 39 Suppl 1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/faculty_pubs/937 | |
dc.identifier.contextkey | 8575149 | |
html.description.abstract | <p>Upregulation of the inflammatory cascade is a major element both in the progression of steatohepatitis to severe alcoholic hepatitis as well as in the progression of NASH to advanced NASH with fibrosis. The mechanisms underpinning these changes are only partially understood. Activation of the inflammatory cascade requires multiple stimuli and in this report, we discuss the role of inflammasomes that activate IL-1beta as well as the sterile and pathogen-derived danger signals that results in inflammasome activation and inflammation in alcoholic and non-alcoholic steatohepatitis. The dynamics of inflammasome activation, the cell types involved and the trigger signals appear to be somewhat different between ASH and NASH. Further studies are needed to dissect the pathology-related differences between these two major forms of steatohepatitis. Clinical and therapeutic implications of inflammasome activation in steatohepatitis are also discussed.</p> | |
dc.identifier.submissionpath | faculty_pubs/937 | |
dc.contributor.department | Graduate School of Biomedical Sciences | |
dc.contributor.department | Department of Medicine, Division of Gastroenterology | |
dc.source.pages | S18-23 |